Related Experiment Video
Updated: Jun 5, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
[Difficult transitions from paediatric to adult care in type 1 Gaucher disease]
N Buchbinder1, M Berger, A Robert
1Service d'hématologie, oncologie et immunologie pédiatriques, CHU Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France. nimrod.buchbinder@chu-rouen.fr
Abstract:
Gaucher disease is the most frequent lysosomal storage disease. It is a progressive chronic disease that can lead to substantial bone and joint damage and hematological cytopenias. This progressive disease severely worsens the patients' quality of life. Over the past 20 years, enzymatic treatment has considerably improved both symptoms and quality of life. Yet, bone and joint damage may be irreversible. This emphasizes the importance of rigorous follow-up so as to begin uninterrupted treatment before lesion onset. The transition from pediatric to adult care is a major concern for chronic patients. This step is often associated with follow-up problems and may lead to disease worsening. We present three cases of patients who were lost to follow-up during the transition phase. For all 3 patients, the disease notably worsened because follow-up was interrupted during this period.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Lysosomal Hydrolases
Pharmacodynamics in Geriatric Patients: Effects of Age